Dealzdewright

I thought I would try to be the first person to leave a message here.
I believe the $EMJX model will set the financial standard with the first Treasury Operating System designed to work through volatility. I’m looking forward to being a long term investor/shareholder in this rising dynasty.

Is anyone else having trouble with buying $GRRR through Fidelity? They have it locked out for app/online trades, allowing only live calls to execute and they won’t give a reason for their action on $GRRR. Just curious if anyone is having this issue with their Fidelity account?

$CANF Hoping this stud gets a prom date soon‼️

Can-Fite Biopharma $CANF has 2 splits
May 10, 2019 - 1 for 15 reverse split
January 09, 2023 - 1 for 10 reverse split

$CANF
March 3rd release highlights Namodenoson's ability to increase adiponectin levels, a key cytokine known to drive multi-organ protective effects. Importantly, the manuscript underscores Namodenoson's dual role as both an anti-cancer therapy and a protective agent for normal tissues, setting it apart from conventional chemotherapy and other oncology treatments with significant toxicity.

That said… what is holding $CANF back❓- I don’t see it.

$CANF
I’ve been watching and aware of Can-Fite for about 18 months. I saw the RS happen when I assume they needed to raise capital but based on what I heard on the investor call this week they have the working capital now to take the company to the next level AND dare I say profitability…

Currently:
18 months money in hand and strong pipeline of potential patients for study. Current phase 2 & 3 trials have created new opportunities for Namodenoson and Piclidenoson - including but not limited to, Pancreatic cancer w/ potential cure, NASH, E.D., weight loss and Disappearance of decompensated liver cirrhosis, just to name a few.

$CANF is being paid millions for development of treatment for Osteoarthritis in dogs. *This alone should make Can-Fite a 4$ stock, imo.

$CANF Did anyone attend the presentation at the BIO CEO & Investor conference? Here’s a company that seems to be doing everything right! I can’t figure out why it’s not doing better in the market. I have personally watched how Pancreatic Cancer can kill someone very quickly. We need CAN-FITE to continue to be a leader in the cure.

$CANF What am I missing??? Been watching this for several months and seems good news only drives the price down. Their break throughs in MASH & Pancreatic cancer alone should be enough to kick it into gear, bypassing any managerial flaws in the company.

$CANF is it just going to be death by a thousand cuts or what…❓‼️

$CANF Make it happen‼️